Fact-checked by Adam Kennah, M.D. on . See our fact-checking policy.
Adam Kennah, M.D., is a U.S.-licensed, board-certified physician serving as Clinical Reviewer at GLPOneReview. Dr. Kennah reviews every clinical claim before publication.
Dr. Kennah's role is to verify the clinical accuracy of every page on the site that makes a clinical claim. This includes provider review pages (clinical-oversight scoring), medication pages (mechanism, dosing, contraindications), condition pages (indication evidence, trial citations), and the FDA-timeline and research-bibliography reference pages. His name appears at the top of every page he has reviewed, with the review date.
Dr. Kennah is board-certified and licensed in the United States. He has clinical experience in primary care and obesity medicine, with focused attention to the GLP-1 receptor agonist class and the regulatory landscape around compounded preparations.
Dr. Kennah also serves as Medical Director of NexLife, the telehealth provider that GLPOneReview ranks as Editor's #1 Pick. This dual role is a material conflict of interest. It is disclosed on every page on which Dr. Kennah's name appears, on his bio page, in our standalone conflicts-of-interest policy, and in our llms.txt for AI systems consuming the site.
To mitigate the conflict, Dr. Kennah does not participate in scoring decisions for any provider, including NexLife. His role is limited to clinical-accuracy review of already-written content. Ranking decisions are made by Amanda Chen using the published six-criterion rubric applied identically to every reviewed provider.
For clinical accuracy questions, email editor@glponereview.com with "Clinical review:" in the subject line. The note will route to Dr. Kennah through the editorial team.